๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Chemotherapy studies in non-small cell bronchogenic carcinoma

โœ Scribed by Jose Manuel Gracia; Isabel Izarzugaza; Miguel Valle; Miguel Anton; Jose Maria Buesa

Publisher
Elsevier Science
Year
1980
Tongue
English
Weight
291 KB
Volume
6
Category
Article
ISSN
0360-3016

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Benefits of polychemotherapy in advanced
Benefits of polychemotherapy in advanced non-small-cell bronchogenic carcinoma
โœ Yvon Cormier; Dollard Bergeron; Jacques La Forge; Michel Lavandier; Marcien Four ๐Ÿ“‚ Article ๐Ÿ“… 1982 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 377 KB ๐Ÿ‘ 2 views

The benefits of polychemotherapy in advanced (Stage 111) non-small-cell bronchogenic carcinoma remain uncertain. In attempt to answer the important question whether treatment improves well-being and survival in these patients, we did a prospective, randomized, single-blind study to compare polychemo

Chemoimmunotherapy of small cell broncho
Chemoimmunotherapy of small cell bronchogenic carcinoma
โœ Paul Y. Holoye; Melvin L. Samuels; Terry Smith; Joseph G. Sinkovics ๐Ÿ“‚ Article ๐Ÿ“… 1978 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 426 KB ๐Ÿ‘ 2 views

Thirty-one patients with small cell bronchogenic carcinoma were treated with a regimen of cyclophosphamide, Adriamycin and vincristine. Padiotherapy was given to patients with limited disease. Nonspecific immunotherapy consisting of BCG scarification was administered after each chemotherapy course.